Acceleron Pharma Inc (XLRN) is up Wednesday morning, with the stock gaining 3.60% in pre-market trading to 180.25. XLRN's short-term technical score of 96 indicates that the stock has traded more bullishly over the last month than 96% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, XLRN ranks higher than 99% of stocks. Acceleron Pharma Inc has risen 0.60% over the past month, closing at $172.51 on October 20. During this period of time, the stock fell as low as $172.51 and as high as $174.89. XLRN has an average analyst recommendation of Sell. The company has an average price target of $179.30.
XLRN has an Overall Score of 72. Find out what this means to you and get the rest of the rankings on XLRN!